ArticleCureus2025
Prevalence of Anxiety and Depression Among Patients With Type 2 Diabetes Mellitus in Eastern Region, Saudi Arabia: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pooled prevalence of anxiety and depressive symptoms among adults with type 2 diabetes: a systematic review and meta-analysis.Journal of diabetes and metabolic disorders · 2026Review
- The relationship between fasting blood glucose, glycated hemoglobin, fructosamine, and depression in patients with type 2 diabetes mellitus in South Korea: a secondary analysis of the Korea National Health and Nutrition Examination Survey VIII-2 (2020) data.Journal of Korean biological nursing science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 diabetes mellitus (T2DM) is a chronic, progressive metabolic disorder frequently associated with depression and anxiety. It is characterized by elevated levels of glucose in the bloodstream. Individuals diagnosed with T2DM encounter an increased risk of various health complications, experience a low quality of life, and contribute to a significant economic burden due to healthcare costs associated with their condition.
objectiveThe objective of this study was to evaluate the prevalence of anxiety and depression in patients with T2DM in the eastern region of Saudi Arabia, as well as to identify the factors that predict this comorbidity, with a focus on glycemic control, treatment adherence, and overall healthcare outcomes. METHODOLOGY: A cross-sectional study was conducted with a sample size of 391 patients, including Saudi and non-Saudi individuals living in the eastern region of Saudi Arabia aged 18 years and older, all diagnosed with T2DM. Participants completed a self-administered online questionnaire that collected data on the sociodemographic background of the patients and their diabetic status. Scores such as the Patient Health Questionnaire-9 (PHQ-9) for depression and the Generalized Anxiety Disorder-7 (GAD-7) for anxiety, as well as their medication adherence, were covered in the final section. All analyses were performed using IBM SPSS Statistics for Windows, Version 26.0 (2019; IBM Corp., Armonk, New York, United States), and descriptive statistics were calculated for the study variables. Chi-square and exact probability tests were used to examine the associations between categorical variables.
resultsMost participants were aged 26-35 years (n=138, 35.3%), and were male (n=262, 67%) and Saudi nationals (n=365, 93.4%). A majority had diabetes for three to five years (n=128, 32.7%), with 196 (50.1%) having glycated hemoglobin (HbA1C) levels of 7-8%. Regarding physical activity, 134 (34.3%) participants reported no exercise and only 21 (5.4%) exercised daily. Additionally, anxiety symptoms were common, with 176 (45%) participants reporting some impact on daily tasks and 185 (47.3%) experiencing depression-related difficulties. Factors significantly associated with anxiety and depression included HbA1C levels, duration of diabetes, and the number of medications prescribed. Medication adherence challenges were prevalent, with 221 (56.5%) patients sometimes forgetting and 134 (34.3%) discontinuing their medication without consulting their physician.
conclusionCrucial factors associated with anxiety in our setting included being non-Saudi, having lower education levels, poor glycemic control, and the number of medications used. Depression, on the other hand, was found to be higher among unemployed patients, those with longer diabetes duration, poor glycemic control, and multiple medications. These findings emphasize the importance of healthcare providers in addressing both the medical and psychological needs of diabetic patients through tailored interventions to enhance their overall well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.